Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

COCHLEAR Aktie

 >COCHLEAR Aktienkurs 
91.31 EUR    +4.1%    (TradegateBSX)
Ask: 92.31 EUR / 77 Stück
Bid: 91.38 EUR / 78 Stück
Tagesumsatz: 172 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
COCHLEAR Aktie über LYNX handeln
>COCHLEAR Performance
1 Woche: +13,4%
1 Monat: +7,1%
3 Monate: +33,7%
6 Monate: +56,4%
1 Jahr: -44,1%
laufendes Jahr: -38,3%
>COCHLEAR Aktie
Name:  COCHLEAR LTD
Land:  Australien
Sektor:  Gesundheit
ISIN/ Wkn:  AU000000COH5 / 898321
Symbol/ Ticker:  OC5 (Frankfurt)
Kürzel:  FRA:OC5, ETR:OC5, OC5:GR
Index:  -
Profil:  Cochlear Limited is a leading global provider of implantable hearing solutions, specializing in cochlear implant systems, bone conduction devices, and sound processor upgrades. Headquartered in Sydney, Australia, the company has over 40 years of expe..
>Volltext..
Marktkapitalisierung:  6012.47 Mio. EUR
Unternehmenswert:  6027.63 Mio. EUR
Umsatz:  1441.78 Mio. EUR
EBITDA:  251.34 Mio. EUR
Nettogewinn:  90.96 Mio. EUR
Gewinn je Aktie:  1.39 EUR
Schulden:  131.35 Mio. EUR
Liquide Mittel:  115.91 Mio. EUR
Operativer Cashflow:  227.26 Mio. EUR
Bargeldquote:  0.31
Umsatzwachstum:  7.54%
Gewinnwachstum:  -58.9%
Dividende je Aktie:  2.12 EUR
Dividendenrendite:  2.35%
Dividendenschätzung:  3.23%
Div. Historie:  21.09.26 - 0.80756€
19.03.26 - 1.3091351€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  COCHLEAR
Letzte Datenerhebung:  25.10.26
>COCHLEAR Kennzahlen
Aktien/ Unternehmen:
Aktien: 65.4 Mio. St.
Frei handelbar: 94.6%
Leerverk. Aktien: -
Rückkaufquote: 0.27%
Mitarbeiter: 5400
Umsatz/Mitarb.: 0.27 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: -4.06%
Bewertung:
KGV: 65.55
KGV lG: 27.39
KUV: 3.71
KBV: 5.54
PEG-Ratio: -
EV/EBITDA: 23.98
Rentabilität:
Bruttomarge: 70.53%
Gewinnmarge: 6.31%
Operative Marge: 12.89%
Managementeffizenz:
Gesamtkaprendite: 5.43%
Eigenkaprendite: 7.98%
>COCHLEAR Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Hörgeräte/ Hörimplantate
 
26.10.26 - 01:48
Would I buy and hold CSL and Cochlear shares for 10 years? (Fool)
 
These two businesses have different growth stories, but both stand out to me long term. The post Would I buy and hold CSL and Cochlear shares for 10 years? appeared first on The Motley Fool Australia....
22.10.26 - 17:57
2026 MERKIN PRIZE IN BIOMEDICAL TECHNOLOGY AWARDED TO FIVE LAUREATES FOR DEVELOPING THE MODERN COCHLEAR IMPLANT (PR Newswire)
 
Graeme Clark, Erwin Hochmair, Ingeborg Hochmair, Michael Merzenich, and Blake Wilson receive the 2026 Merkin Prize at the Broad Institute for the modern cochlear implant This groundbreaking medical device is used by more than one million people around the world to hear and engage in......
21.10.26 - 02:12
Cochlear shares jump 9% in a week: Can they break past $150? (Fool)
 
The shares are climbing higher into the green again on Wednesday. The post Cochlear shares jump 9% in a week: Can they break past $150? appeared first on The Motley Fool Australia....
20.10.26 - 14:42
Envoy Medical, Inc.: Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design (Newsfile)
 
Company Believes It Is the First to Reach This Milestone in a U.S. Pivotal Trial of a Fully Implanted Cochlear ImplantRemains on Track to Reach 12-Month Visit Milestone by Early Q2 2027 and Submit ......
19.10.26 - 13:42
Health Care Roundup: Market Talk (WSJ EN)
 
Find insight on CSL, Cochlear, Suzuken and more in the latest Market Talks covering Health Care....
14.10.26 - 17:06
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026 (PR Newswire)
 
Newsweek's World's Most Trustworthy Companies 2026 Ranks Cochlear as Top Healthcare & Life Sciences Company LONE TREE, Colo., Oct. 14, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been ranked No. 1 in the Health Care &......
12.10.26 - 14:48
Envoy Medical, Inc.: Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant (Newsfile)
 
Second of Four Planned Modules Moves Rolling FDA Review ForwardAdvances Toward Targeted Completion of the Final Clinical Module Submission in Q2 2027White Bear Lake, Minnesota--(Newsfile Corp. - Oc......
07.10.26 - 03:00
AGL, Cochlear, WiseTech shares: Buy, hold, sell (Fool)
 
Find out what brokers expect next for these ASX shares. The post AGL, Cochlear, WiseTech shares: Buy, hold, sell appeared first on The Motley Fool Australia....
29.09.26 - 06:01
Cochlear Aktie nach Ankündigung einer Sammelklage unter Druck (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
29.09.26 - 03:00
Cochlear shares fall as investors face another setback (Fool)
 
Cochlear shares are back in the red. The post Cochlear shares fall as investors face another setback appeared first on The Motley Fool Australia....
22.09.26 - 06:36
South32, Cochlear, Westpac shares: Buy, hold or sell? (Fool)
 
One of these ASX shares is tipped to fall around 10%. The post South32, Cochlear, Westpac shares: Buy, hold or sell? appeared first on The Motley Fool Australia....
17.09.26 - 21:48
13 ASX shares with ex-dividend dates next week (Fool)
 
Shares going ex-dividend include Cochlear, New Hope Corporation, Latitude, and St Barbara. The post 13 ASX shares with ex-dividend dates next week appeared first on The Motley Fool Australia....
16.09.26 - 04:24
Cochlear share price rebounds 53% from 10-year low: Can it keep climbing? (Fool)
 
The shares are still down 47% for the year-to-date. The post Cochlear share price rebounds 53% from 10-year low: Can it keep climbing? appeared first on The Motley Fool Australia....
16.09.26 - 01:24
Cochlear vs Pro Medicus: Which beaten-down ASX healthcare share is the better buy today? (Fool)
 
We compare Cochlear and Pro Medicus after major share price declines. See which ASX healthcare stock I'd lean towards today. The post Cochlear vs Pro Medicus: Which beaten-down ASX healthcare share is the better buy today? appeared first on The Motley Fool Australia....
20.08.26 - 08:00
Buy, hold, sell: SRG Global, Cochlear, NAB shares (Fool)
 
As earnings season continues, Morgans has updated its ratings after scrutinising company reports. The post Buy, hold, sell: SRG Global, Cochlear, NAB shares appeared first on The Motley Fool Australia....
20.08.26 - 04:36
Why I′d buy CSL, Cochlear, and Pro Medicus shares (Fool)
 
These are three ASX healthcare shares I would be happy to own for years. The post Why I'd buy CSL, Cochlear, and Pro Medicus shares appeared first on The Motley Fool Australia....
19.08.26 - 05:00
Buy $5,000 of Cochlear shares today and it could be worth this much in 12 months (Fool)
 
Find out what brokers tip for this ASX healthcare stock next. The post Buy $5,000 of Cochlear shares today and it could be worth this much in 12 months appeared first on The Motley Fool Australia....
18.08.26 - 21:45
Cochlear reports FY results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.08.26 - 18:36
Health Care Roundup: Market Talk (WSJ EN)
 
Find insight on Ipca Laboratories, Cochlear and more in the latest Market Talks covering the health care sector....
18.08.26 - 07:42
Cochlear Limited Reveals Drop In Full Year Income (AFX)
 
CANBERA (dpa-AFX) - Cochlear Limited (COH.AX) reported a profit for full year that Drops, from the same period last yearThe company's bottom line totaled A$147.3 million, or A$2.248 per share. Thi......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Alle Musik ist eigentlich innere Musik und muß immer wieder zu innerer Musik werden. - Gerhart Hauptmann
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!